New Weight-Loss shot shows promise in chinese trial
NCT ID NCT06256562
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an experimental injection called GZR18 in 340 Chinese adults who are obese or overweight. The goal was to see if it helps with weight loss over 30 weeks compared to a placebo. Participants also followed a stable diet and exercise plan. The results will show how much weight people lost and if the treatment is safe.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gan & Lee Pharmaceuticals Co., Ltd
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?